null
null
OncologyStat
®
One Source, Many Resources.
®
By Elsevier
BREAST CANCER
Refine Results:
All Categories
Epidemiology and Etiology (624)
Prevention and Screening (456)
Diagnosis and Staging (718)
Treatment (1547)
Supportive Oncology (177)
CME
CaseLine: HER2-Positive Breast Cancer
An interactive CME program provided by Educational Concepts Group, LLC
Monica Visit 2: A 36-Year-Old Female with Early Stage Breast Cancer, Returning for Follow-up
An interactive CME program powered by Real CME
Clinically Challenging Case Series: Breast Cancer-Related Bone Disease
Monica Visit 1: A 36-Year-Old Female with Early Stage Breast Cancer
An interactive CME program powered by Real CME
Karen Visit 2: A 49-Year-Old Female with Early Stage Breast Cancer, Returning for Follow-up
An interactive CME program powered by RealCME
More CME ›
News
Bevacizumab Boosts Treatment Responses in Early Breast Cancer
Elsevier Global Medical News, 2012 Jan 25, S Worcester
Trastuzumab Bests Lapatinib for HER2 Breast Cancer
Elsevier Global Medical News, 2012 Jan 17, S Worcester
Safety of Skin-Sparing Mastectomy Confirmed Short-Term
Elsevier Global Medical News, 2012 Jan 10, D Mahoney
Less Trastuzumab Cardiotoxicity in Beta-Blocker Users
Elsevier Global Medical News, 2012 Jan 4, B Jancin
Program Curbs Shoulder Morbidity Post Breast Cancer
Elsevier Global Medical News, 2012 Jan 4, B Jancin
More News ›
Journal Scans: Research
High Non-Compliance in the Use of Letrozole After 2.5 Years of Extended Adjuvant Endocrine Therapy. Results From the IDEAL Randomized Trial
Eur J Surg Oncol, 2012 Feb 1, DBY Fontein, et al
Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer
N Engl J Med, 2012 Jan 26, G von Minckwitz, et al
EXPERT COMMENTARY
Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer
N Engl J Med, 2012 Jan 26, H Bear, et al
Neoadjuvant Anastrozole Versus Tamoxifen in Patients Receiving Goserelin for Premenopausal Breast Cancer (STAGE): A Double-Blind, Randomised Phase 3 Trial
Lancet Oncol, 2012 Jan 20, N Masuda, et al
Lapatinib With Trastuzumab for HER2-Positive Early Breast Cancer (NeoALTTO): A Randomised, Open-Label, Multicentre, Phase 3 Trial
Lancet, 2012 Jan 16, J Baselga, et al
More Journal Scans: Research ›
Journal Scans: Review
Target Therapy in Elderly Breast Cancer Patients
Crit Rev Oncol Hematol, 2012 Jan 16, P Carli, et al
Breast Cancer Occurred After Hodgkin's Disease: Clinico-Pathological Features, Treatments and Outcome: Analysis of 214 Cases
Crit Rev Oncol Hematol, 2012 Jan 1, B Cutuli, et al
Clinical Review - Breast Adenoid Cystic Carcinoma
Breast, 2011 Dec 9, N Boujelbene, et al
Management of Non Metastatic Phyllodes Tumors of the Breast: Review of the Literature
Surg Oncol, 2011 Dec 1, P Khosravi-Shahi
Treatment of Metastatic Breast Cancer: State-of-the-Art, Subtypes and Perspectives
Crit Rev Oncol Hematol, 2011 Dec 1, NS El Saghir, et al
More Journal Scans: Review ›
Expert Opinion
Ask the Expert: Applying BOLERO-2 to the “Hormone-Refractory” Patient
2012 Jan 30, Clifford Hudis, et al
Ask the Expert: What’s the Role for Post-Mastectomy Radiation and Chemotherapy in Node-Positive Breast Cancer?
2012 Jan 30, Clifford Hudis, et al
Ask the Expert: Should I Use Adjuvant Therapy in DCIS?
2012 Jan 30, Clifford Hudis, et al
Ask the Expert: Optimal Chemotherapy for Metastatic TNBC?
2012 Jan 30, Clifford Hudis, et al
Ask the Expert: Optimal Treatment for ER+, HER2− Early-Stage Breast Cancer in Males
2012 Jan 30, Clifford Hudis, et al
More Expert Opinion ›
Chemotherapy Regimens
Hormone therapy (Breast)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Trastuzumab, vinorelbine (Breast)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
TH (paclitaxel, trastuzumab [Herceptin])
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
TC (docetaxel, cyclophosphamide) (Breast)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
TAC (doxetaxel, doxorubicin [Adriamycin], cyclophosphamide) (Breast)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
More Chemotherapy Regimens ›
Conference Coverage
2011 San Antonio Breast Cancer Symposium
Dec 6-10 2011 San Antonio, et al
2011 Breast Cancer Symposium
Sept 8-10 2011 San Francisco, et al
33rd Annual San Antonio Breast Cancer Symposium
Dec 8-12 2010 San Antonio, et al
Videos
Personalized Medicine: A Long Way to Go
EJC News Focus, 2011 Nov 1
Breast Cancer Drug T-DM1 Shows Promise in Trial
Elsevier Global Medical News, 2011 Oct 13, K Wachter
Therapy Didn’t Increase Postmenopausal Breast Density
Elsevier Global Medical News, 2011 Oct 3
Taking Pills to Prevent Breast Cancer
Elsevier Global Medical News, 2011 Jun 5
Expert Gives Overview of Gamechangers at 2011 ASCO Annual Meeting
Elsevier Global Medical News, 2011 Jun 4
More Videos ›
Summary of Key Points
Cancer of the Breast
Abeloff's Clinical Oncology, 4th ed. 2008
Comment
Print page
Share page
RSS feeds
Updated Key Points: Breast Cancer
Summary information about breast cancer has been completely revised with updated information from Abeloff's Clinical Oncology, 4th ed.
Read more ›
Editors' Choice
Long-Term Posttransplant Bortezomib Boosts Outcome in Myeloma With del(17p13)
Read more ›
Commentary
Ten Practice Changes I Will Make After Attending ASCO 2011
Read more ›
Categories
News
Journal Scans
Expert Opinion
Drugs and Regimens
Conferences
CME
Videos
Supportive Care
Skeletal-Related Events
Complications, GI and Oral
Hematologic Support
Infectious Complications
Neurologic Complications
Pain
Vascular Complications
Cancer Type
Bladder
Bone
Breast
Breast (ER-Positive)
CNS/Brain
Colon and Rectum
Endocrine System
Esophagus
GYN (Non-Ovary)
GYN (Ovary)
Head and Neck
Hodgkin's Lymphoma
Kidney (Renal Cell)
Leukemia
Liver and Bile Duct
Lung
Multiple Myeloma
Myelodysplastic Syndrome
Myeloproliferative Diseases
Non-Hodgkin's Lymphoma
Pancreas
Pediatric Cancers
Prostate
Rare Cancers
Skin
Soft-Tissue Sarcoma
Stomach
Testicle
Breast/
anonymous
none
none
none
n
Advanced Search
Email Address
Password
Remember Me
Forgot your password?
Not a member?
Free registration
Elsevier
Home
Site Map
Cancer Types
About OncologySTAT
Privacy Policy
Terms of Use
Contact Us
Advertise
Copyright © 2012
Elsevier Inc.
All rights reserved.